Adjunct extended‐release valproate semisodium in late life schizophrenia

200720 citationsJournal Articlebronze Open Access

Authors

Martha Sajatovic · Case Western Reserve University

Nicoleta Coconcea · OhioHealth

Rosalinda V. Ignacio · Health Services Research & Development

Frederic C. Blow · Health Services Research & Development

Robert W. Hays · NorthEast Ohio Neighborhood Health Services

Kristin A. Cassidy · Case Western Reserve University

William J. Meyer

Abstract

While extended-release valproate semisodium appears efficacious and well tolerated in older adults with schizophrenia, data from larger, controlled trials is needed.

Topics & Keywords

Schizophrenia research and treatment Pharmacological Effects and Toxicity Studies Epilepsy research and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Geriatric Psychiatry

Volume 23, Issue 2, pp. 142-147

DOI: 10.1002/gps.1854

Field-Weighted Citation Impact: 0.82